CERCAM and metabolic dysfunction-associated steatotic liver disease: Few studies of RHBDF1, THY1, MXRA8,FKBP10, PGF, SPON1, COL4A2, TMPRSS3, QSOX1, AGPAT4, COL5A1, CERCAM and COL8A2 have been reported at present in the field of NAFLD.